ProShare Advisors
SBBP

ProShare Advisors’s Strongbridge Biopharma plc. SBBP Stock Holding History

ProShare Advisors’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,763
Closed -$32K – 2436
2021
Q1 		$32K Buy
+11,763
New +$35.5K ﹤0.01% 2251
2019
Q4 		– Sell
-18,794
Closed -$45K – 1816
2019
Q3 		$45K Buy
18,794
+2,986
+19% +$8.02K ﹤0.01% 1607
2019
Q2 		$49K Sell
15,808
-2,590
-14% -$9.51K ﹤0.01% 1575
2019
Q1 		$92K Buy
18,398
+2,403
+15% +$11.8K ﹤0.01% 1582
2018
Q4 		$72K Sell
15,995
-3,054
-16% -$14.9K ﹤0.01% 1509
2018
Q3 		$92K Sell
19,049
-86
-0.4% -$440 ﹤0.01% 1692
2018
Q2 		$115K Sell
19,135
-5,325
-22% -$39K ﹤0.01% 1694
2018
Q1 		$216K Buy
24,460
+1,757
+8% +$13.2K ﹤0.01% 1513
2017
Q4 		$165K Buy
+22,703
New +$142K ﹤0.01% 1676

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

ProShare Advisors's SBBP Position: Q2 2021 in Review

ProShare Advisors sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 11,763 shares — an estimated $32K sold.

ProShare Advisors first reported a position in SBBP in Q4 2017 and held it in 9 quarters. The position peaked at $216K in Q1 2018. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • ProShare Advisors reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • ProShare Advisors sold 11,763 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $32K.
  • ProShare Advisors first reported a position in Strongbridge Biopharma plc. in Q4 2017 and held it in 9 quarters.
  • ProShare Advisors's Strongbridge Biopharma plc. position peaked at $216K in Q1 2018.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.